✓ Independent editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Categories · Multi-Specialty Directory

Peptide & Therapy Categories

Released: Last reviewed:

Browse U.S. telehealth providers and peptide therapeutics across six therapeutic categories. NexLife is scored on our v4.1 methodology (seven weighted categories, 100 points); other providers’ scores are from our May 2026 review (v3.0 rubric), with v4.1 re-scores pending.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Therapeutic categories

W
Weight Loss
GLP-1 receptor agonists for chronic weight management
6 peptides · 6 top providers reviewed
View category →
R
Recovery
Tissue repair, injury recovery, and inflammation control
7 peptides · 5 top providers reviewed
View category →
L
Longevity
Cellular aging, telomere maintenance, mitochondrial function
6 peptides · 5 top providers reviewed
View category →
C
Cognitive Enhancement
Memory, focus, neurogenesis, neuroprotection
6 peptides · 5 top providers reviewed
View category →
G
Growth Hormone
GH secretagogues, IGF-1 modulation, lean mass support
9 peptides · 5 top providers reviewed
View category →
S
Sexual Health
Libido, arousal, hormone modulation
5 peptides · 5 top providers reviewed
View category →

Why category matters

Telehealth providers are not interchangeable across therapeutic categories. A GLP-1-focused provider like NexLife has very different operational requirements (named 503A pharmacies, clinician oversight of dose changes, cardiovascular safety review) than a longevity provider that dispenses NAD+ or epithalon (research-grade peptides, lab integration for biomarkers). Match the provider to the use case.

Editorial team

Researched by Dr. Parmis (Medical Researcher, Western University of Health Sciences); medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).